Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Osielsko – page 19

917 clinical trials in Osielsko, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Osielsko at a glance
917
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

917 trials in Osielsko

Open in trial search

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Psychotic disorder+2

Recruiting

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study of L-Annamycin and Cytarabine for Adults with Refractory or Relapsed Acute Myeloid Leukemia

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Annamycin
  • Sponsor:Moleculin Biotech Inc.

Study on IV NEPA (Fosnetupitant/Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Fosaprepitant
  • Sponsor:Helsinn Healthcare S.A.

Gastric cancer+3

Recruiting

Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Shanghai Henlius Biotech Inc.

Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Budigalimab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:University Of Cologne

Hypertension

Recruiting

Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Amlodipine
  • Sponsor:Agencja Badań Medycznych

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:Ascentage Pharma Group Inc.

Study Comparing BMS-986489 with Chemotherapy to Atezolizumab with Chemotherapy for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Osielsko

What the registry says about research in the country

01 Psoriasis Research

Comprehensive clinical trials focusing on moderate to severe plaque psoriasis, including studies evaluating new therapeutic approaches for patients with special area involvement.

  • Treatment evaluation for special areas
  • Long-term safety assessments
  • Novel therapeutic compounds

Multiple innovative treatments being tested to improve patient outcomes and quality of life.

02 Vitiligo Studies

Advanced research into nonsegmental vitiligo treatments, exploring both oral medications and systemic therapies for long-term management.

  • Efficacy trials for new medications
  • Long-term safety evaluations
  • Adult and adolescent treatments

Focused on developing sustainable treatment options for vitiligo patients.

03 Dermatological Conditions

Investigating treatments for various skin conditions including chronic hand eczema and alopecia areata.

  • Atopic hand eczema therapies
  • Severe alopecia treatments
  • Safety and tolerability studies

Comprehensive research aimed at addressing challenging dermatological conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.